Osaka Medical and Pharmaceutical University · Department of Urogenital and Developmental Medicine · 助教

Research keywordsprostate cancer・urothelial carcinoma・androgen receptor inhibitors・immunotherapy outcomes・metastatic burden・tumor microenvironment

Research fieldsUrology

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Real-world comparison of enzalutamide and apalutamide in metastatic hormone-sensitive prostate cancer: a multi-institutional propensity score-matched analysis.2026 · Japanese journal of clinical oncology
• Discordance between PSA level and bone metastatic volume is associated with unfavourable prognosis.2026 · BJU international / 137 / 2
• Age-stratified clinical outcomes and adverse events in patients with metastatic castration-sensitive prostate cancer receiving triplet therapy with darolutamide, androgen deprivation therapy, and docetaxel.2026 · Japanese journal of clinical oncology
• Prognostic impact of lung metastasis in patients treated with androgen receptor signaling inhibitors for castration-sensitive prostate cancer: data from the ULTRA-Japan Consortium.2026 · Japanese journal of clinical oncology / 56 / 1

• Official profile